FMRP (Ser499) Antibody from PHOSPHOSOLUTIONS

Search, find, compare suppliers for anti-FMRP (Ser499) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityFMRP (Ser499)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieschicken, human, mouse, and rat (expected: bovine, canine, nonhuman primate, sheep, Xenopus, zebrafish)
Isotypen/a
Formatantigen affinity purified
Size100 µL
Concentrationn/a
ApplicationsWB, IHC. RUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRabbit anti-FMRP (Ser499) polyclonal antibody. Specific for endogenous levels of the ~71 kDa FMRP protein phosphorylated at Ser499. Immunolabeling is completely eliminated by treatment with λ-phosphatase. RRID: AB_2492094
ImmunogenSynthetic phospho-peptide corresponding to amino acid residues surrounding Ser499 of rat FMRP, conjugated to keyhole limpet hemocyanin (KLH).
Other Namesphospho- , phosphorylated FMR 1 antibody, Fmr1 antibody, Fmr1 gene antibody, FMR1_HUMAN antibody, FMRP antibody, Fragile X mental retardation 1 antibody, Fragile X mental retardation 1 protein antibody, Fragile X mental retardation protein 1 antibody, Fragile X mental retardation protein antibody, fragile X mental retardation syndrome-related protein 1 antibody, fragile X mental retardation autosomal homolog 1 antibody, FRAXA antibody, fxr1 antibody, MGC87458 antibody, POF antibody, POF1 antibody, Protein FMR-1 antibody, Protein FMR1 antibody, wu:fb16f11 antibody, wu:fd18c10 antibody, zgc:66226 antibody
Gene, Accession #FMR1, UniProt: Q80WE1, NCBI: 24948
Catalog #p1125-499
Price$430
Order / More InfoFMRP (Ser499) Antibody from PHOSPHOSOLUTIONS
Product Specific Referencesn/a
PHOSPHOSOLUTIONS
PHOSPHOSOLUTIONS
PHOSPHOSOLUTIONS
Colorado Biosciences Park
12635 East Montview Blvd. #213
Aurora CO 80045-7337
P: 720-859-4050
P: 888-442-7100
F: 720-859-4052

info@phosphosolutions.com

http://www.phosphosolutions.com

Profile of PHOSPHOSOLUTIONS

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.